Centre of Research Excellence in Redefining
Antimicrobial Use to Reduce Resistance CRE REDUCE
Site search

BLING III: A phase III randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients

Funding source: 
National Health and Medical Research Council

Project members

Professor Jeffrey Lipman

Professor Jason Roberts

CRE Director

Professor Jean-Yves Lefrant

Professor John Myburgh

Professor David Paterson

Professor Jan De Waele